K
Kancera AB
STO:KAN
Kancera AB
STO:KAN
Price:
0.1598
SEK
4.99%
Market Closed
Market Cap:
kr19.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kancera AB
STO:KAN
|
SE |
|
Unity Software Inc
NYSE:U
|
US |
|
UK Commercial Property REIT Ltd
LSE:UKCM
|
GG |
|
Z
|
Zealand Pharma A/S
OTC:ZLDPF
|
DK |
|
K
|
Kyungdong Invest Co Ltd
KRX:012320
|
KR |
|
Medley Inc
TSE:4480
|
JP |
|
Mitsubishi Corp
TSE:8058
|
JP |
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Nyxoah SA
XBRU:NYXH
|
BE |
|
Lar Espana Real Estate SOCIMI SA
MAD:LRE
|
ES |
|
Hakuyosha Co Ltd
TSE:9731
|
JP |
|
Lu Thai Textile Co Ltd
SZSE:000726
|
CN |
|
G
|
G3 Exploration Ltd
LSE:G3E
|
CN |
|
K
|
Keypath Education International Inc
ASX:KED
|
US |
Balance Sheet
Balance Sheet Decomposition
Kancera AB
Kancera AB
Balance Sheet Decomposition is not available for
Kancera AB
Kancera AB
Balance Sheet
Kancera AB
Kancera AB
Currency: SEK
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
7
|
21
|
5
|
14
|
23
|
16
|
58
|
28
|
21
|
12
|
55
|
107
|
95
|
46
|
46
|
16
|
|
| Cash Equivalents |
7
|
21
|
5
|
14
|
23
|
16
|
58
|
28
|
21
|
12
|
55
|
107
|
95
|
46
|
46
|
16
|
|
| Total Receivables |
1
|
3
|
0
|
1
|
1
|
1
|
1
|
3
|
5
|
3
|
6
|
3
|
4
|
2
|
3
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
5
|
2
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
6
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
8
|
24
|
5
|
15
|
27
|
18
|
65
|
33
|
27
|
16
|
61
|
112
|
99
|
48
|
49
|
17
|
|
| PP&E Net |
0
|
10
|
0
|
4
|
4
|
3
|
2
|
1
|
0
|
5
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
10
|
0
|
4
|
4
|
3
|
0
|
0
|
0
|
5
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
4
|
0
|
1
|
0
|
3
|
0
|
0
|
5
|
8
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
6
|
6
|
6
|
6
|
6
|
6
|
6
|
18
|
18
|
24
|
21
|
21
|
21
|
18
|
18
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
14
N/A
|
40
+184%
|
11
-72%
|
26
+127%
|
36
+42%
|
27
-25%
|
73
+166%
|
51
-30%
|
46
-11%
|
44
-3%
|
83
+87%
|
133
+61%
|
121
-9%
|
66
-46%
|
67
+2%
|
17
-75%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
0
|
2
|
0
|
3
|
1
|
1
|
2
|
3
|
6
|
2
|
2
|
4
|
3
|
3
|
3
|
0
|
|
| Accrued Liabilities |
0
|
3
|
1
|
2
|
2
|
1
|
4
|
4
|
2
|
3
|
4
|
4
|
7
|
15
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
2
|
0
|
0
|
5
|
1
|
5
|
2
|
3
|
4
|
3
|
2
|
4
|
1
|
1
|
1
|
|
| Total Current Liabilities |
3
|
7
|
1
|
5
|
8
|
4
|
11
|
10
|
12
|
26
|
10
|
10
|
14
|
18
|
5
|
2
|
|
| Long-Term Debt |
0
|
2
|
0
|
2
|
2
|
2
|
3
|
3
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
14
+371%
|
1
-92%
|
7
+519%
|
9
+36%
|
5
-40%
|
14
+146%
|
13
-7%
|
12
-3%
|
27
+121%
|
11
-60%
|
11
+0%
|
14
+27%
|
18
+30%
|
5
-74%
|
2
-64%
|
|
| Equity | |||||||||||||||||
| Common Stock |
0
|
0
|
2
|
3
|
3
|
9
|
11
|
12
|
16
|
17
|
40
|
47
|
66
|
8
|
12
|
12
|
|
| Retained Earnings |
0
|
26
|
24
|
7
|
15
|
19
|
56
|
113
|
46
|
36
|
48
|
308
|
361
|
366
|
410
|
456
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
384
|
402
|
406
|
461
|
459
|
|
| Other Equity |
11
|
51
|
32
|
8
|
34
|
32
|
105
|
140
|
63
|
36
|
80
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
11
N/A
|
26
+134%
|
10
-61%
|
19
+85%
|
27
+44%
|
22
-20%
|
60
+171%
|
39
-35%
|
33
-14%
|
17
-48%
|
72
+315%
|
123
+70%
|
107
-13%
|
48
-55%
|
62
+31%
|
15
-76%
|
|
| Total Liabilities & Equity |
14
N/A
|
40
+184%
|
11
-72%
|
26
+127%
|
36
+42%
|
27
-25%
|
73
+166%
|
51
-30%
|
46
-11%
|
44
-3%
|
83
+87%
|
133
+61%
|
121
-9%
|
66
-46%
|
67
+2%
|
17
-75%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
15
|
24
|
29
|
39
|
119
|
130
|
18
|
20
|
24
|
26
|
56
|
67
|
81
|
83
|
121
|
121
|
|
Switch to:
Switch to:
See Also
Discover More
